Brief Report: Arthritis in KRN T Cell Receptor-Transgenic Mice Does Not Require Interleukin-17 or Th17 Cells.
Brief Report: Arthritis in KRN T Cell Receptor-Transgenic Mice Does Not Require Interleukin-17 or Th17 Cells.
复制标题
DOI:
10.1002/art.39646
复制
发表时间:
2016-08
期刊:
影响因子:
--
通讯作者:
Binstadt BA
中科院分区:
文献类型:
--
作者:
Auger JL;Cowan HM;Engelson BJ;Kashem SW;Prinz I;Binstadt BA
Th17 cells and interleukin (IL)-17 cytokine family members are implicated in the pathogenesis of many rheumatic diseases. Most studies of mouse models of inflammatory arthritis have demonstrated a key role for the pro-inflammatory cytokine IL-17A and its receptor, the IL-17 receptor (IL-17R) A/C heterodimer. Using a rigorous genetic approach, we evaluated the contribution of Th17 cells and IL-17 in the autoantibody-dependent, KRN T cell receptor (TCR) transgenic mouse model of arthritis. We bred KRN mice expressing the MHCII molecule Ag7 (K/B/g7) and genetically lacking the related cytokines IL-17A and IL-17F or their critical receptor subunit, IL-17RA. Using bone marrow transplantation, we generated mice in which K/B/g7 hematopoietic donor cells lacked the key Th17-differentiating transcription factor, Rorγt. K/B/g7 mice lacking both IL-17A and IL-17F produced normal titers of pathogenic autoantibodies and developed arthritis normally. Similarly, IL-17RA was not required for disease development in this model, nor was Rorγt expression by hematopoietic cells. Despite prior reports suggesting that Th17 cells and IL-17A are crucially involved in the pathogenesis of arthritis in K/BxN mice, the results presented here provide genetic evidence that IL-17A and IL-17F, IL-17RA, and hematopoietic cell Rorγt expression are dispensable for normal arthritis progression in the K/B/g7 model system. We discuss potential explanations for the discrepancies between these two highly similar model systems. These findings plus those from other mouse models of arthritis provide insight regarding why biologic therapeutics targeting the Th17/IL-17 axis are beneficial in some human rheumatic diseases but not others.